Vaxfab Enterprises Hits Upper Circuit Amidst Unprecedented Buying Interest

On 19 Nov 2025, Vaxfab Enterprises demonstrated a day change of 1.98%, significantly outperforming the Sensex which recorded a modest 0.30% gain. This performance is part of a broader trend where the stock has been steadily gaining ground, supported by robust investor demand and sustained upward price movement. The stock has recorded consecutive gains over the last two days, delivering a cumulative return of 4.02% during this period.

Examining the moving averages, Vaxfab Enterprises is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a strong bullish trend across multiple timeframes. This technical positioning often attracts further buying interest as investors perceive the stock to be in a sustained uptrend.

Looking at the performance over various periods, Vaxfab Enterprises has demonstrated exceptional returns relative to the Sensex benchmark. Over the past month, the stock has delivered an 11.13% return compared to the Sensex’s 1.17%. The three-month performance is particularly striking, with a 90.58% gain against the Sensex’s 4.03%. Over the year, the stock’s return stands at an impressive 390.46%, dwarfing the Sensex’s 9.48% gain. Year-to-date, Vaxfab Enterprises has returned 261.62%, while the Sensex has recorded 8.69%.

Over a longer horizon, the three-year performance of Vaxfab Enterprises is 141.29%, compared to the Sensex’s 37.73%. However, the stock shows no recorded returns over the five and ten-year periods, which may indicate a more recent listing or restructuring event. The market cap grade of 4 reflects a mid-cap status, consistent with its sector classification in Trading & Distributors.

The current market scenario for Vaxfab Enterprises is unique due to the presence of only buy orders in the order book, a situation that is rarely observed in the equity markets. This absence of sellers has resulted in the stock hitting its upper circuit limit, preventing any downward price movement. Such a scenario often leads to a multi-day upper circuit, as the demand continues to outstrip supply, and sellers remain absent or unwilling to transact at lower prices.

Investors should note that while the upper circuit reflects strong buying enthusiasm, it also implies limited liquidity on the sell side, which can lead to price volatility once the circuit limits are lifted. The stock’s mojo score currently stands at 60.0 with a hold grade, following an adjustment in evaluation from a previous sell grade on 23 Oct 2025. This revision in its score aligns with the recent surge in buying interest and price momentum.

Sector-wise, Vaxfab Enterprises has outperformed its Trading & Distributors peers, with a day performance exceeding the sector average by 2.17%. This outperformance highlights the stock’s relative strength within its industry group, further supported by the sustained buying interest and technical indicators.

Given the extraordinary buying pressure and the stock’s position above all key moving averages, market participants may anticipate continued momentum in the near term. However, the unique condition of having only buy orders in the queue warrants caution, as it may lead to sharp price corrections once sellers re-enter the market or circuit limits are adjusted.

In summary, Vaxfab Enterprises is currently experiencing a rare market event characterised by an upper circuit with no sellers, reflecting extraordinary demand and a potential multi-day circuit scenario. Its strong performance across multiple timeframes, combined with technical strength and sector outperformance, positions it as a notable stock within the Trading & Distributors sector. Investors should monitor order book dynamics closely to gauge the sustainability of this momentum.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →